The combination use of inclisiran and statins versus statins alone in the treatment of dyslipidemia in mainland China: a cost-effectiveness analysis.
Journal Information
Journal Title: Front Pharmacol
Detailed journal information not available.
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
"The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was based on the Hong Kong and Macao Drug and Medical Device Policy and was funded by the Science and Technology Innovation Project (2021TDB28) of the Guangdong Provincial Drug Administration."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025